Scarica l'app Stockscreener
166.94
1.13%
-1.91
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
IQVIA Duke Alliance Highlights Obesity Trials And Potential Valuation Upside - Sahm
IQVIA Holdings Inc.: Inside the Data, AI, and Capital Strategy Shaping Its Next Chapter! - Smartkarma
Is the Options Market Predicting a Spike in IQVIA Stock? - TradingView
US prescriptions for Novo's Wegovy pill were 38,220 (not '38,909') for week ended Feb 6IQVIA data shared by analyst shows - marketscreener.com
Rhumbline Advisers Sells 25,227 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc (IQV) Shares Gap Down to $166.13 on Feb 12 - GuruFocus
The Top 5 Analyst Questions From IQVIA's Q4 Earnings Call - Finviz
Earnings growth of 3.6% over 3 years hasn't been enough to translate into positive returns for IQVIA Holdings (NYSE:IQV) shareholders - Yahoo Finance
75,170 Shares in IQVIA Holdings Inc. $IQV Purchased by Eubel Brady & Suttman Asset Management Inc. - MarketBeat
Cornerstone Investment Partners LLC Raises Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Will IQVIA Holdings Inc. benefit from sector rotationEarnings Growth Summary & Risk Adjusted Swing Trade Ideas - mfd.ru
IQVIA Holdings Inc (IQV) Shares Gap Down to $186.065 on Feb 10 - GuruFocus
Global obesity trials get boost from new IQVIA–Duke research pact - Stock Titan
Compagnie Lombard Odier SCmA Cuts Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Aug EndMonth: Is IQVIA Holdings Inc stock influenced by commodity pricesTrade Performance Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
IQVIA revenue for Q4 2025 up 10.3% to USD 4,364M - Medical Buyer
Candriam S.C.A. Grows Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings, Inc. (IQV) Stock Analysis: A Promising 31.93% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
IQVIA Expands AI Data Partnerships As Investors Weigh Growth Prospects - Yahoo Finance
Rally Mode: Is Vipshop Holdings Limited Depositary Receipt subject to activist investor interestQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
IQVIA Holdings (IQV) Valuation Check After Profit Guidance Disappoints Despite Solid Quarterly Revenue Beat - Sahm
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: IQVIA Holdings (IQV) and Molina Healthcare (MOH) - The Globe and Mail
Thrivent Financial for Lutherans Has $5.76 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Envestnet Asset Management Inc. Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Fell 19% This Week. Could Shares Push Toward $260 in 2026? - TIKR.com
Jefferies lowers IQVIA stock price target to $255 on margin pressures By Investing.com - Investing.com South Africa
IQVIA Leans On AI And Boehringer Deal As Shares Struggle - Sahm
IQVIA Q4 Earnings Call Highlights - Yahoo Finance
Jefferies lowers IQVIA stock price target to $255 on margin pressures - Investing.com UK
IQV: JP Morgan Lowers Price Target While Maintaining Overweight Rating | IQV Stock News - GuruFocus
IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns By Investing.com - Investing.com Australia
UBS Adjusts IQVIA Holdings (IQV) Price Target to $240 Amidst Ste - GuruFocus
Jefferies Lowers Price Target for IQVIA Holdings (IQV) to $255 | - GuruFocus
IQV Analyst Rating Update: Stifel Lowers Price Target to $220 | IQV Stock News - GuruFocus
Barclays Analyst Lowers Price Target for IQV to $210 | IQV Stock News - GuruFocus
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term - Yahoo Finance
Leerink Partners Adjusts Price Target on IQVIA Holdings to $228 From $256, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on IQVIA Holdings to $225 From $250, Maintains Outperform Rating - marketscreener.com
Barclays Adjusts IQVIA Price Target to $210 From $230, Maintains Equal Weight Rating - marketscreener.com
JPMorgan Adjusts IQVIA Price Target to $225 From $255, Maintains Overweight Rating - marketscreener.com
Citigroup Adjusts IQVIA Price Target to $200 From $230, Maintains Neutral Rating - marketscreener.com
IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis - Finviz
TD Waterhouse Canada Inc. Sells 16,903 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings Inc. (NYSE:IQV) Q4 2025 Earnings Call Transcript - Insider Monkey
Jefferies Adjusts Price Target on IQVIA Holdings to $255 From $270, Maintains Buy Rating - marketscreener.com
Stifel Adjusts Price Target on IQVIA Holdings to $220 From $273, Maintains Buy Rating - marketscreener.com
IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Omnicell (OMCL) and MiMedx Group (MDXG) - The Globe and Mail
IQVIA Slipped 1% on AI Pivot: Why the Stock Could Rebound to $303 in 2026? - TIKR.com
Research Alert: CFRA Maintains Buy Rating On Shares Of Iqvia Holdings Inc. - 富途牛牛
IQVIA Q4 2025 slides: Revenue jumps 10.3%, stock falls despite beat - Investing.com Nigeria
IQVIA (IQV) Stock Trades Down, Here Is Why - Finviz
IQVIA Holdings (IQV) Q4 2025 Earnings Call Transcript - Fortune
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y - The Globe and Mail
IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
IQVIA Stock Drops as 2026 Outlook Misses Wall Street Expectations - Blockonomi
IQVIA backs AI strategy as analysts question impact on business - marketscreener.com
Key facts: IQVIA Q4 2025 revenue rises 10.3%; shares drop 8%; new segment launched - TradingView
IQVIA Holdings Inc (IQV) Stock Price Down 8.17% on Feb 5 - GuruFocus
IQVIA (IQV) Q4 2025 Earnings Call Transcript - The Globe and Mail
IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance - BioSpace
IQVIA (IQV) Shares Dip Despite Beating Q4 2025 Expectations - GuruFocus
0.77%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):